Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA(1c) and fasting plasma glucose

BACKGROUND: Recent epidemiological studies indicate that only 30–50% of undiagnosed type 2 diabetes mellitus (T2DM) patients are identified using glycated hemoglobin (HbA(1c)) and elevated fasting plasma glucose (FPG) levels. Thus, novel biomarkers for early diagnosis and prognosis are urgently need...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiller, Sandro, Li, Yichao, Blüher, Matthias, Welch, Lonnie, Hoffmann, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370432/
https://www.ncbi.nlm.nih.gov/pubmed/28360826
http://dx.doi.org/10.1186/s12014-017-9145-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370432/
https://www.ncbi.nlm.nih.gov/pubmed/28360826
http://dx.doi.org/10.1186/s12014-017-9145-1

Ejemplares similares